We are live on ! Find out more
MGNX icon

MacroGenics

146 hedge funds and large institutions have $259M invested in MacroGenics in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 52 increasing their positions, 48 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 48

6.69% less ownership

Funds ownership: 103.83%97.14% (-6.7%)

10% less funds holding

Funds holding: 163146 (-17)

37% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 43

42% less call options, than puts

Call options by funds: $1.14M | Put options by funds: $1.97M

73% less capital invested

Capital invested by funds: $954M → $259M (-$695M)

Holders
146
Holders Change
-17
Holders Change %
-10.43%
% of All Funds
2.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
27
Increased
52
Reduced
48
Closed
43
Calls
$1.14M
Puts
$1.97M
Net Calls
-$825K
Net Calls Change
-$15.1M

MGNX Hedge Fund Activity: Q2 2024 in Review

146 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2024, worth a combined $259M — down 73% from $954M a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of MGNX and 27 opened new positions — a net loss of 16 holders — while 48 trimmed existing stakes and 52 added.

The largest buyer was Armistice Capital, adding an estimated $35.1M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $90.5M sold.

  • 146 institutional investors held MacroGenics (MGNX) as of Q2 2024, down from 163 in Q1 2024.
  • Funds reported $259M of MacroGenics stock for Q2 2024, down 73% quarter-over-quarter.
  • 27 funds opened new MacroGenics positions in Q2 2024 and 43 closed out, a net change of -16 holders.
  • The largest MacroGenics buyer in Q2 2024 was Armistice Capital, an estimated $35.1M added.
  • The largest MacroGenics seller in Q2 2024 was Avoro Capital Advisors, an estimated $90.5M sold.

Based on aggregated 13F filings for Q2 2024.